Neuca SA
WSE:NEU
Relative Value
The Relative Value of one NEU stock under the Base Case scenario is hidden PLN. Compared to the current market price of 722 PLN, Neuca SA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
NEU Competitors Multiples
Neuca SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
N
|
Neuca SA
WSE:NEU
|
3.4B PLN | 0.2 | 21.5 | 9.5 | 14.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
113.2B USD | 0.3 | 26.1 | 18.3 | 20.6 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
65B USD | 0.2 | 40 | 14.1 | 17.8 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.3B USD | 0.2 | 39 | 13.8 | 17.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 30.1 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.8B AUD | 2.6 | 33.4 | 24.8 | 24.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.7B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 0.6 | 21.3 | 10.4 | 14.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.6B HKD | 0.1 | 8.3 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |